• RN Home
  • About RocketNews
    • About RocketNews
    • Article Submission Form
    • Commercial News Posting and Writing Services
    • Contact RocketNews
  • News Categories
    • Business
    • Climate Change
    • Education
    • Energy
    • Entertainment
    • Financial
    • Health
    • Jobs
    • Politics
    • Religion
    • Science
    • Sports
    • Stock Market News
    • Technology
    • Top Stories
    • Travel
    • World

Regional sports networks are faltering even as ratings soar

by News Feed Editor | Apr 2, 2026 | Business

In this articleCMCSACHTRSSPFollow your favorite stocksCREATE FREE ACCOUNTLos Angeles Dodgers pitcher Yoshinobu Yamamoto and actor and musician Donald Glover greet Nintendo’s Yoshi after the ceremonial first pitch before a baseball game against the Cleveland...

I started a business at 16 to make money. Now I’m building generational wealth. – Business Insider

by News Feed Editor | Apr 2, 2026 | Business

I started a business at 16 to make money. Now I’m building generational wealth.  Business Insider Article Attribution | Read More at Article Source

Givers’ regret: What happens when wealthy parents try to claw back fortunes from their kids

by News Feed Editor | Apr 2, 2026 | Business

Thomas Barwick | Digitalvision | Getty ImagesA version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your...

Thorne is on pace for $650 million in sales as Gen Z fuels a supplement boom — despite subscription fatigue

by News Feed Editor | Apr 2, 2026 | Business

Supplement brand Thorne is on pace to reach $650 million in annual revenue this year, fueled by Gen Z and millennial shoppers who are increasingly focused on improving their health, CNBC has learned. The 42-year-old supplement brand, which L Catterton took private in...

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

by News Feed Editor | Apr 1, 2026 | Business

In this articleLLYFollow your favorite stocksCREATE FREE ACCOUNTThe U.S. Food and Drug Administration approved Eli Lilly’s GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss...

Visa launches new AI tools to manage the charge dispute process

by News Feed Editor | Apr 1, 2026 | Business

In this articleVFollow your favorite stocksCREATE FREE ACCOUNTVisa Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, Jan. 28, 2026.Michael Nagle | Bloomberg | Getty ImagesVisa is launching six new tools using artificial...
« Older Entries
Next Entries »

Recent Posts

  • Taking salsa classes can improve mental health, Oxford study suggests
  • NI health: Consultants and specialist doctors take strike action
  • A year into a national guard deployment, DC residents say they live in ‘a city under siege’
  • A year into a national guard deployment, DC residents say they live in ‘a city under siege’
  • Republicans threaten Canada with sanctions over drifting wildfire smoke

Recent Comments

No comments to show.

About RN

Rocketnews is an aggregator of the top online news articles and stories from around the globe. Rocketnews uses news feeds from a variety on online news feed providers including Feedzilla, Yahoo, and the BBC. Addition news feed providers included online media suppliers, local and regional publications, industry journals, companies, governments, universities, PR companies, official organizations, associations, shopping guides and weblogs. Featured content providers include Reuters, Metacafe, News Corporation, About, BBC and The Sun.

Website Awards

2004 Webby Award Nomination

RocketNews nominated for a Webby Award

Search Engine Watch past honorable mention winner for Best News Search Engine.

More Info

About RocketNews

Contact RocketNews

COVID-19 Dashboard

Definitions and Terms

Privacy Policy

Site Design and Operation by Murray Owen LLC | A Web Development and Operations Company